Here are the S-3 shelf registrations from Coya Therapeutics, Inc. (COYA) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-3 covers the shelf registration that lets an established company sell over time, so if you follow COYA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full COYA filings page.
Coya Therapeutics, Inc. registers for resale 2,522,727 shares of common stock issued in a January 29, 2026 private placement. The prospectus states these Shares were issued in the Private Placement at $4.40 per share and that the Company will receive no proceeds from resales by the selling stockholders.
The filing lists selling holders (including Greenlight Capital and Dr. Reddy’s), describes allowable methods of resale, and confirms the Company will pay registration expenses. Shares outstanding were 23,457,183 as of March 10, 2026.